+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A case of Whipple's disease with ankylosing spondylarthritis treated with trimethoprim-sulfamethoxazole



A case of Whipple's disease with ankylosing spondylarthritis treated with trimethoprim-sulfamethoxazole



Annales de Gastroenterologie et d'Hepatologie 27(2): 51-55



We report the case of a patient, suffering from Whipple's disease and HLA B27 positive ankylosing spondylitis with syndesmophytes and erosive discopathy. Since spinal radiographic aspects of spondylitis due to Whipple's disease are unusual, we are debating on their relation. We, then, took an interest in the treatment given to this patient: trimethoprim-sulfamethoxazole which would now appear to be the best antibiotic for Whipple's disease.

(PDF emailed within 1 workday: $29.90)

Accession: 039031333

Download citation: RISBibTeXText

PMID: 1713437


Related references

Whipple's disease: acquired resistance to trimethoprim-sulfamethoxazole. American Journal of Gastroenterology 95(9): 2390-2391, 2000

Whipple's disease, successful response to sulfamethoxazole-trimethoprim. American Journal of Gastroenterology 75(4): 309-310, 1981

Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple's disease. Journal of Antimicrobial ChemoTherapy 65(9): 2005-2012, 2010

An evaluation of antimicrobial treatment for Whipple's Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Digestive Diseases and Sciences 39(8): 1642-1648, 1994

Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. Journal of Infection 66(3): 263-270, 2013

Acquired resistance to trimethoprim-sulfamethoxazole during Whipple disease and expression of the causative target gene. Journal of Infectious Diseases 198(1): 101-108, 2008

Absorption and urinary execretion of trimethoprim, sulfamethoxazole, and trimethoprim-sulfamethoxazole: results with single doses in normal young adults and preliminary observations during therapy with trimethoprim-sulfamethoxazole. Journal of Infectious Diseases 128: Suppl:584-99 P, 1973

Central nervous system Whipple's disease: relapse during therapy with trimethoprim-sulfamethoxazole and remission with cefixime. Gastroenterology 106(3): 782-786, 1994

Reversal of dementia associated with Whipple's disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Gastroenterology 86(4): 745-752, 1984

Trimethoprim-sulfamethoxazole-resistant pneumococcal disease in a pediatric acquired immunodeficiency syndrome patient receiving trimethoprim-sulfamethoxazole prophylaxis. Pediatric Infectious Disease Journal 13(5): 423-424, 1994

Sulfamethoxazole-trimethoprim double-blind, placebo-controlled, crossover trial in Machado-Joseph disease: Sulfamethoxazole-trimethoprim increases cerebrospinal fluid level of biopterin. Journal of Neural Transmission General Section 102(2): 159-172, 1995

The in vitro demonstration of the efficacy of trimethoprim as an antibacterial agent in a comparative bacteriological study of the effects of trimethoprim, sulfamethoxazole and the combination trimethoprim-sulfamethoxazole. ChemoTherapy 18(4): 242-252, 1973

Non-debilitating forms of ankylosing spondylarthritis; fortunate discovery of three cases of ankylosing spondylarthritis which remained latent during the course of their development. Revue du Rhumatisme et des Maladies Osteo-Articulaires 25(4): 304-305, 1958